Your Article Summary
See Latest ArticlesThe combination of docetaxel and cisplatin plus fluorouracil as neoadjuvant chemotherapy in the treatment of T4 stage gastric cancer
Surgical Oncology, 07/02/09
Guo MG et al. - In a review of the use of docetaxel and cisplatin plus fluorouracil as neoadjuvant chemotherapy in treatment of T4 stage gastric cancer, it was concluded that those who responded to docetaxel–cisplatin–fluorouracil, exhibited T downstaging, and subsequently received an R0 resection had a better chance of a cure vs surgery alone, according to a complete 3-yr follow-up.
Methods- Prognosis of local advanced gastric carcinoma is very poor.
- Impact on survival and the effects induced by the triple combination docetaxel–cisplatin–fluorouracil (DCF) as neoadjuvant chemotherapy was evaluated in 24 T4 stage gastric tumor pts.
- They received 2–3 cycles DCF chemotherapy, followed by radical gastric resection.
- Tumor downstaging detected by CT was obtained in 17 of 24 pts.
- Overall 3-yr survival rate was 68.2%.
- Pts who received R0 resection (19/22) showed a 3-yr survival rate of 78.9%.
- T downstaged pts (17/22) showed a higher 3-yr survival rate of 82.4%.
Related Articles
Nodal staging score: A tool to assess adequate staging of node-negative colon cancer
Journal of Clinical Oncology, 11/16/09
Relevance Score: 81%
Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer
Medical Oncology, 11/10/09
Relevance Score: 81%
Expression of L1 Cell Adhesion Molecule Is a Significant Prognostic Factor in pT3-stage Gastric Cancer
Anticancer Research, 11/10/09
Relevance Score: 81%
An evidence-based consensus statement on the role and application of endosonography in clinical practice
Endoscopy, 10/30/09
Relevance Score: 81%
The prognostic significance of bladder neck invasion in prostate cancer: is microscopic involvement truly a T4 disease
BJU International, 11/06/09
Relevance Score: 80%
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
The Journal of Pathology, 12/11/09
Extracapsular lymph node spread
Cancer, 12/11/09
Variations in gastric cancer care
Cancer, 12/11/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Benefit of Allogeneic Melanoma Cell Lysate–Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
Clinical Cancer Research, 12/11/09
Radiation Therapy for Rectal Cancer: Current Status and Future Directions
Cancer Control, 12/11/09
Current Progress in Targeted Therapy for Colorectal Cancer
Cancer Control, 12/11/09